The effect of food and an antacid on the bioavailability of dexketoprofen trometamol

Journal of Clinical Pharmacology

Volumn 38, Issue 12 SUPPL., 1998, Pages

  McEwen, John ^a   De Luca, Massimo ^b   Casini, Alessandro ^b   Gich, Ignasi ^c   Barbanoj, Manel J ^c   Tost, Digna ^d   Artigas, Remei ^d   Mauleón, David ^d  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b Menarini Ricerche SpA   (Italy)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d Laboratorios Menarini SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM MAGNESIUM HYDROXIDE; ANTACID AGENT; DEXKETOPROFEN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; FOOD DRUG INTERACTION; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0032416945     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcph.1998.38.s1.41     Document Type: Article

References (18)

1. Gleeson S, Sorbie J: Efficacy of ketoprofen in treating primary dysmenorrhea. Can Med Assoc 1983;129:842-844.
2. Sunshine A, Olson NZ: Analgesic efficacy of ketoprofen in postpartum, general surgery and chronic cancer pain. J Clin Pharmacol 1988;28(Suppl.):47-54.
3. Veys EM: 20 years' experience with ketoprofen. Scand J Rheumatol Suppl 1991;90:1-44.
4. Suesa N, Fernández MF, Gutiérrez M, Rufat MJ, Rotllan E, Calvo L, Mauleón D, Carganico G: Stereoselective cyclooxygenase inhibition in cellular models by the enantiomers of ketoprofen. Chirality 1993;5:589-595.
5. Hayball PJ: Chirality and nonsteroidal anti-inflammatory drugs. Drugs 1996;52(Suppl. 5):47-58.
6. Evans AM: Pharmacodynamics and pharmacokinetics of the profens: enantioselectivity, clinical implications and special reference to S(+)-ibuprofen. J Clin Pharmacol 1996;36:7S-15S.
7. Gich I, Bayés M., Barbanoj MJ, Artigas R, Tost D, Mauleón D: Bioinversion of R(-)-ketoprofen after oral administration in healthy volunteers. Clin Drug Invest 1996;11:347-353.
8. Mauleón D, Artigas R, García LL, Carganico G: Preclinical and clinical development of dexketoprofen. Drugs 1996;52(Suppl. 5): 24-46.
9. Shumaker RC. A BASIC interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metab Rev 1986;17:331-348.
10. Shuirmann DJ: A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J Pharmacokinet Biopharm 1987;15:657-680.
11. Wijnand HP, Timmer CJ: Mini-computer programs for bioequivalence testing of pharmaceutical drug formulations in two-way crossover studies. Comput Prog Biomed 1983;17:73-78.
12. Bannwarth B, Lapicque F, Netter P, Monot C, Tamisier JN, Thomas P, Royer RJ: The effect of food on the systemic availability of ketoprofen. Eur J Clin Pharmacol 1988;33:643-645.
13. Williams RL, Upton RA: The clinical pharmacology of ketoprofen. J Clin Pharmacol 1988;28:S13-22.
14. Zmeili S, Hasan M, Najib N, et al: Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs Inflaban: effect of food on Inflaban bioavailability. Int J Clin Pharmacol Ther 1996;12:564-570.
15. Coates PE, Mesure R: Pharmacokinetics of tenidap sodium administered with food or antacid in healthy volunteers. Br J Clin Pharmacol 1995;39:17S-19S.
16. Pargal A, Kelkar M, Nayak PJ: The effect of food on the bioavailability of ibuprofen and flurbiprofen from sustained release formulations. Biopharm Drug Dispos 1996;17:511-519.
17. Davies NM, Anderson KE: Clinical pharmacokinetics of naproxen. Clin Pharmacokinet 1997;32:268-293.
18. Orme MLE: The relationship between the plasma concentration of non-steroidal anti-inflammatory drugs and their therapeutic effects. Agents Actions 1985;17:151-155.